Ubs Asset Management Americas Inc Amicus Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,255,803 shares of FOLD stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,255,803
Previous 1,072,474
17.09%
Holding current value
$10.3 Million
Previous $8.75 Million
17.78%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding FOLD
# of Institutions
302Shares Held
332MCall Options Held
396KPut Options Held
249K-
Vanguard Group Inc Valley Forge, PA29.4MShares$241 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA29.1MShares$239 Million0.03% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$200 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY18MShares$148 Million1.88% of portfolio
-
William Blair Investment Management, LLC Chicago, IL14.6MShares$120 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.3B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...